Bausch Health Companies Inc. (BHC) Financial Statements (2024 and earlier)

Company Profile

Business Address 2150 ST. ELZEAR BLVD. WEST
QUEBEC, QC H7L 4A8
State of Incorp. NJ
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5645826053,243721720
Cash and cash equivalents5645826053,243721720
Restricted cash and investments  1,2111277
Receivables1,7901,7751,5771,8391,8652,130
Inventory, net of allowances, customer advances and progress billings1,0909931,0941,1079341,048
Inventory1,0909931,0941,1079341,048
Prepaid expense      7
Other undisclosed current assets8032,257855779689764
Total current assets:4,2475,6075,3426,9694,2114,746
Noncurrent Assets
Property, plant and equipment1,6001,5981,5671,4661,3531,403
Intangible assets, net (including goodwill)17,34719,40521,48923,32725,14330,804
Goodwill11,54712,45713,04413,12613,14215,593
Intangible assets, net (excluding goodwill)5,8006,9488,44510,20112,00115,211
Disposal group, including discontinued operation, noncurrent assets      12
Deferred income tax assets2,1662,2522,1371,690
Other noncurrent assets32634066441110999
Other undisclosed noncurrent assets     1,676433
Total noncurrent assets:21,43923,59525,85726,89428,28132,751
TOTAL ASSETS:25,68629,20231,19933,86332,49237,497
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5095,1984,9135,0143,6084,059
Accounts payable521407337503411365
Accrued liabilities2,9884,7914,5764,5113,1973,694
Debt432  1,234228209
Total current liabilities:3,9415,1984,9136,2483,8364,268
Noncurrent Liabilities
Long-term debt and lease obligation20,33422,65423,92524,66124,07725,235
Long-term debt, excluding current maturities20,33422,65423,92524,66124,07725,235
Liabilities, other than long-term debt9431,1821,5401,556879890
Deferred income tax liabilities202529528705
Estimated litigation liability      20
Other liabilities7416531,012851581526
Business combination, contingent consideration, liability    298344
Other undisclosed noncurrent liabilities 2082022162628851,160
Total noncurrent liabilities:21,48524,03825,68126,47925,84127,285
Total liabilities:25,42629,23630,59432,72729,67731,553
Equity
Equity, attributable to parent(692)(106)5351,0632,7335,849
Common stock10,39110,31710,22710,17210,12110,090
Additional paid in capital159462454429413380
Accumulated other comprehensive loss(2,056)(1,924)(2,133)(2,086)(2,137)(1,896)
Accumulated deficit(9,186)(8,961)(8,013)(7,452)(5,664)(2,725)
Equity, attributable to noncontrolling interest9527270738295
Total equity:260(34)6051,1362,8155,944
TOTAL LIABILITIES AND EQUITY:25,68629,20231,19933,86332,49237,497

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues8,1248,4348,0278,6018,3808,724
Revenue, net8,724
Cost of revenue(4,501)(4,661)(4,396)(5,673)(7,287)(4,908)
Cost of goods and services sold      (2,548)
Gross profit:3,6233,7733,6312,9281,0933,816
Operating expenses(3,169)(3,323)(2,955)(3,131)(3,477)(3,714)
Other operating income (expense), net(35)(373)(454)(1,414)21353
Other undisclosed operating income (loss)353734541,414(21)(353)
Operating income (loss):454450676(203)(2,384)102
Nonoperating income (expense)614(17)2034119
Investment income, nonoperating14713121112
Gain (loss), foreign currency transaction, before tax(8)7(30)823107
Interest and debt expense(589)(1,426)(1,534)(1,612)(1,685)(1,840)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (59)(42)(119)(122)
Loss from continuing operations before equity method investments, income taxes:(129)(962)(934)(1,837)(4,154)(1,741)
Other undisclosed loss from continuing operations before income taxes  (62)    
Loss from continuing operations before income taxes:(129)(1,024)(934)(1,837)(4,154)(1,741)
Income tax expense (benefit)(83)8737554104,145
Income (loss) from continuing operations:(212)(937)(559)(1,783)(4,144)2,404
Income (loss) before gain (loss) on sale of properties:(937)(559)(1,783)(4,144)2,404
Net income (loss):(212)(937)(559)(1,783)(4,144)2,404
Net income (loss) attributable to noncontrolling interest(13)(11)(1)(5)(4) 
Net income (loss) available to common stockholders, diluted:(225)(948)(560)(1,788)(4,148)2,404

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(212)(937)(559)(1,783)(4,144)2,404
Other comprehensive income (loss)(256)(130)(45)50(244)217
Comprehensive income (loss):(468)(1,067)(604)(1,733)(4,388)2,621
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(26)(12)(3)(4)(1)(4)
Comprehensive income (loss), net of tax, attributable to parent:(494)(1,079)(607)(1,737)(4,389)2,617

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: